Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography, and the nuclear imaging modalities of PET and SPECT.

Insurer illegally forcing women to pay for breast imaging, class action lawsuit contends
Lauren Moody and her attorneys believe the damages against Oscar Health could climb to $30M when factoring in interest, attorney fees and fines.
AI detects twice as many incidental lesions as radiologists
Prior research has suggested that these incidental lesions turn out to be cancerous in up to 70% of cases, making their timely detection critical.
A closer look at GE HealthCare's new lower-cost cardiac CT scanner
As cardiac CT continues to get used more and more, GE HealthCare has launched a new scanner designed to meet the needs of both outpatient imaging centers and larger hospitals.
RadNet enters ultrasound AI, acquiring imaging vendor See-Mode Technologies
Founded in 2017, the Melbourne, Australia-based company offers software that analyzes breast and thyroid images, “producing fast and accurate radiology reports.”
Earlier treatment with Pluvicto may be beneficial for patients with hormone-sensitive prostate cancer
The drug has shown a “clinically meaningful benefit” in these patients, suggesting its potential as an earlier treatment option than previously thought, Novartis reports.

AI beats standard regression models at predicting lung cancer risk

Not all AI or regression models are the same, nor do they all incorporate the same data when assessing patient risk.

Standard transthoracic imaging planes for comprehensive right heart assessment. Several key views should be included in the standard echocardiographic assessment of the right heart. Image and caption courtesy of the American Society of Echocardiography.

ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH.

New radiopharmaceutical targeted at gastrointenstinal cancers yields impressive results

Trial results thus far indicate the drug can significantly extend progression-free survival compared to current standard of care treatments.

SCAI President James Hermiller, MD, discusses the need for more better radiation protection in the cath lab#SCAI #CathLab, #RadiationExposure #cardiology

SCAI leaders 'on a mission' to improve cath lab protection from radiation, orthopedic injury

SCAI President James Hermiller, Jr., MD, explains the need for more innovative radiation protection systems in the cath lab.

Aclarion, a company using remote MRIs to assess back pain, expands in partnership with RadNet

The publicly traded Broomfield, Colorado, firm plans to bolster access to its Nociscan product across key markets in New York and New Jersey.

New PET method combines antibody with radioactive isotope to improve lung cancer detection

By giving providers greater insight into a tumor’s molecular footprint, the method could also reduce the need for invasive biopsies.

Experts identify 'critical window' when early signs of neurodegeneration become visible on imaging

These findings may lead to new screening guidelines that could change how imaging is utilized in the aging population.

Building a successful CCTA program: Physicians and healthcare executives to share advice

CCTA continues to grow more and more important in the day-to-day treatment of heart patients. Hospitals and health systems that fail to embrace the modality risk falling behind.

Medical Imaging

Insurer illegally forcing women to pay for breast imaging, class action lawsuit contends

AI detects twice as many incidental lesions as radiologists

A closer look at GE HealthCare's new lower-cost cardiac CT scanner

RadNet enters ultrasound AI, acquiring imaging vendor See-Mode Technologies

Earlier treatment with Pluvicto may be beneficial for patients with hormone-sensitive prostate cancer